ARCHIVES

Bristol-Lyers Squibb, Axion In Joint Venture To Sell Oncology Drugs to Office-Base Practices

This article is from The Cancer Letter archive.

Vol. 19 No. 34 | September 3, 1993

Download PDF Visit The Full Archive

Related Articles

Melanoma Cancer Vaccine Tested By Cooperative Group

August 29, 2003

In Sign-Off Of Two Orphan Drugs, ODAC Leaves Efficacy Interpretation To Docs

November 27, 1998

Wyngaarden Opens Up Search for NCI Director, Invites Recommendations From Cancer Groups

September 30, 1988

In Brief: ASCO Selects Four New Board Members; Mount Sinai’s Shank To Move To California

March 27, 1998

Carter Request Only $878.8 Million For NCI

January 27, 1978

Pretreatment with Azacitidine Achieves 28-Month Remission

August 30, 2013